Erratum To: Sevelamer Is Cost Effective Versus Calcium Carbonate for the First-Line Treatment of Hyperphosphatemia in New Patients to Hemodialysis: A Patient-Level Economic Evaluation of the INDEPENDENT-HD Study
Journal of Nephrology - United States
doi 10.1007/s40620-014-0128-2
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 7, 2014
Authors
Publisher
Springer Science and Business Media LLC